cytidine has been researched along with Carcinoma, Non-Small Cell Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, KS; Cannataro, VL; Das, RK; Dasari, K; Gaffney, SG; Gould Rothberg, BE; Jackson, LK; Kudalkar, S; Lazowski, HM; Townsend, JP; Yildiz, I | 1 |
| Chen, M; Giaccone, G; Kaye, FJ; Marquez, VE; Steeg, PS; Voeller, D; Zajac-Kaye, M | 1 |
2 other study(ies) available for cytidine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
APOBEC mutagenesis and selection for NFE2L2 contribute to the origin of lung squamous-cell carcinoma.
Topics: Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cytidine; Cytidine Deaminase; Humans; Lung; Lung Neoplasms; Minor Histocompatibility Antigens; Mutagenesis; Mutation; NF-E2-Related Factor 2 | 2022 |
Enhanced growth inhibition by combined DNA methylation/HDAC inhibitors in lung tumor cells with silenced CDKN2A.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; CpG Islands; Cytidine; Depsipeptides; DNA Methylation; DNA Modification Methylases; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Gene Deletion; Gene Expression Regulation, Neoplastic; Gene Silencing; Genes, p16; Histone Deacetylase Inhibitors; Humans; Lung Neoplasms; Precision Medicine; Time Factors | 2010 |